MARKET

ZGNX

ZGNX

Zogenix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

54.55
-0.43
-0.78%
Closed 16:41 01/21 EST
OPEN
55.45
PREV CLOSE
54.98
HIGH
56.01
LOW
54.04
VOLUME
733.87K
TURNOVER
--
52 WEEK HIGH
57.22
52 WEEK LOW
35.25
MARKET CAP
2.41B
P/E (TTM)
-6.0566
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZGNX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ZGNX News

  • The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
  • Benzinga.4d ago
  • Hedge Fund Favorites vs. Zogenix, Inc. (ZGNX) In 2019
  • Insider Monkey.12/26/2019 16:53
  • Zogenix announces positive Fintepla results
  • seekingalpha.12/18/2019 05:52
  • The Lancet Publishes Phase 3 Trial Results for Zogenix Investigational Drug FINTEPLA® in Dravet Syndrome
  • GlobeNewswire.12/18/2019 00:04

More

Industry

Biotechnology & Medical Research
-0.61%
Pharmaceuticals & Medical Research
-0.39%

Hot Stocks

Name
Price
%Change

About ZGNX

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders. Its primary area of therapeutic focus is epilepsy and related seizure disorders. Its lead product candidate, ZX008, is a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. ZX008 has received orphan drug designation in the United States and European Union (EU), for the treatment of Dravet syndrome. The Company has an additional product candidate, Relday (risperidone once-monthly long-acting injectable) for the treatment of schizophrenia. Relday is a long-acting injectable formulation of risperidone. Risperidone is used to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. It has completed the Phase I program for Relday.
More

Webull offers Zogenix, Inc. (ZGNX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.